Recent publications

  1. Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation. Verhaak C, de Laat P, Koene S, Tibosch M, Rodenburg R, de Groot I, Knoop H, Janssen M, Smeitink J. Orphanet J Rare Dis. 2016 Mar 18;11(1):25. doi: 10.1186/s13023-016-0403-5. PubMed PMID: 26988355; PubMed Central PMCID: PMC4797235.

  2. High prevalence of complementary and alternative medicine use in patients with genetically proven mitochondrial disorders. Franik S, Huidekoper HH, Visser G, de Vries M, de Boer L, Hermans-Peters M, Rodenburg R, Verhaak C, Vlieger AM, Smeitink JA, Janssen MC, Wortmann SB. J Inherit Metab Dis. 2014 Oct 11. [Epub ahead of print].

  3. Towards the harmonization of outcome measures in children with mitochondrial disorders. Koene S, Jansen M, Verhaak CM, De Vrueh RL, De Groot IJ, Smeitink JA. Dev Med Child Neurol. 2013 Aug;55(8):698-706.

  4. Major depression in adolescent children consecutively diagnosed with mitochondrial disorder. Koene S, Kozicz TL, Rodenburg RJ, Verhaak CM, de Vries MC, Wortmann S, van de Heuvel L, Smeitink JA, Morava E. J Affect Disord. 2009 Apr;114(1-3):327-32.

Search Results